JYSZ2100537 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2021-12-17 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG;Takeda (China) International Trading Co Ltd | | | view |
JYSB2200166 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-24 | | Bayer Healthcare LLC | | | view |
CXSB2400122 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | Supplementary Application | 2024-10-13 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
CYSB2101190 | 人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-09-17 | | Shanxi Kangbao Biological Product Co Ltd | | | view |
JYSB2300036 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2023-02-23 | | Bayer Healthcare LLC | | | view |
CXSS2200013 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2022-02-07 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
JXSS2200007 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-01-26 | | Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd | | | view |
CXSL2400210 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2024-04-03 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
CYSB2101002 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-03-06 | | Shandong Taibang Biological Products Co Ltd | | | view |
JYSB2200164 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-24 | | Bayer Healthcare LLC | | | view |
CXSL2300639 | 注射用重组人凝血因子Ⅷ-Fc融合蛋白 | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein | Lyophilized | Biological Products(2.4) | New Drug Application | 2023-09-21 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
JYSB2200092 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-09 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
CYSB2200010 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2022-01-10 | | SinoCelltech Ltd | | | view |
CYSB2400134 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2024-05-24 | | SinoCelltech Ltd | | | view |
JXSS2200003 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-01-26 | | Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd | | | view |
JYSB2200094 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-09 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
CXSS2200054 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2022-05-27 | | Shenzhen Weiguang Biological Products Co Ltd | | | view |
JYSB2400249 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-12-04 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
JYSB2101161 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-11-10 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
JYSB2400158 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-07-16 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |